よむ、つかう、まなぶ。
【参考１】診療の手引き・第8.1版 (25 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00332.html |
| 出典情報 | 「新型コロナウイルス感染症 COVID－19）診療の手引き・第8.1版」の周知について（10／5付 事務連絡）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
●新型コロナウイルス感染症（COVID-19） 診療の手引き・第 8.1 版 ●２ 臨床像
・Hoenigl M，et al. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet
Microb 2022.
・Horiuchi H，et al. COVID-19-related thrombosis in Japan: Final report of a questionnaire-based survey in 2020. J
Atheroscler Thromb 2021.
・Hou YJ，et al. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell 2020.
・Kanegaye JT，et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics 2009.
・Koehler P，et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM
consensus criteria for research and clinical guidance. Lancet Infect Dis 2021.
・Komine-Aizawa S，et al. Placental barrier against COVID-19. Placenta 2020.
・Lansbury L，et al. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect 2020.
・Made CI，et al. Presence of genetic variants among young men with severe COVID-19. JAMA 2020.
・Matsunaga N，et al. Clinical epidemiology of hospitalized patients with COVID-19 in Japan: Report of the COVID-19
REGISTRY JAPAN. Clin Infect Dis 2020.
・Menni C，et al. Symptom prevalence，duration，and risk of hospital admission in individuals infected with SARS-CoV-2
during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.
Lancet 2022.
・Mi SH，et al. Viral RNA load in mildly symptomatic and asymptomatic children with COVID-19，Seoul. Emerg Infect Dis
2020.
・Miller E，et al. Transmission of SARS-CoV-2 in the household setting: a prospective cohort study in children and adults
in England. J Infect 2021.
・Miyazato Y，et al. Prolonged and late-onset symptoms of coronavirus disease 2019. Open Forum Infect Dis 2020.
・Nalbandian A，et al. Post-acute COVID-19 syndrome. Nat Med 2021.
・Nishimoto Y，et al. The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan:
from the CLOT-COVID study. J Cardiol 2022.
・Oxley TJ，et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 2020.
・Patel A，et al. Multicenter epidemiologic study of coronavirus disease–associated mucormycosis，India. Emerg Infect Dis
2021．
・Peckham H，et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission.
Nat Commun 2020.
・Prattes J，et al. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a
multinational observational study by the European Confederation of Medical Mycology. Clin Microbiol Infect 2021.
・Riphagen S，et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020.
・Sakurai A，et al. Natural history of asymptomatic SARS-CoV-2 infection. N Engl J Med 2020.
・Salim SH，et al. In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study. BMJ 2020.
・Saurabh R，et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19
Infection. JAMA 2020.
・Shoji K，et al. Comparison of the clinical characteristics and outcomes of COVID-19 in children before and after the
emergence of Delta variant of concern in Japan. J Infect Chemother 2022.
・Sigal A，et al. Estimating disease severity of Omicron and Delta SARS-CoV-2 infections. Nat Rev Immunol 2022.
・Sudre CH，et al. Attributes and predictors of long COVID-19. Nat Med 2021.
・Summary of a report of 72，314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020.
・Takasago S，et al. Case report: Changes in cytokine kinetics during the course of disease in a Japanese patient with
multisystem inflammatory syndrome in children. Front Pediatr 2021.
・Takashita E，et al. Efficacy of antibodies and antiviral drugs against Covid-19 omicron variant. N Engl J Med 2022.
・Takazono T，et al. COVID-19 associated pulmonary aspergillosis: a nationwide survey by the Japanese Respiratory
Society. ERJ Open Res 2021.
・Uchida M，et al: Multisystem inflammatory syndrome in children ― A new syndrome complicated with acute heart
failure
following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Infection ―. Circ J 2021.
・UK Office for National Statistics. Comparing the risk of death involving coronavirus (COVID-19) by variant，England:
December 2021. 22 Feb 2022.
・Verdoni L，et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an
observational cohort study. Lancet 2020.
・Wei SQ，et al. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ
2021.
・WHO. COVID-19 Clinical management Living guidance. 23 Nov 2021.
・Wichmann D，et al. Autopsy findings and venous thromboembolism in patients with Covid-19. Ann Intern Med 2020.
・Wu Z，et al. Characteristics of and important lessons from the coronavirus disease 2019（COVID-19）outbreak in China :
Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020.
・Xie Y，et al. Long-term cardiovascular outcomes of COVID-19. Nat Med 2022.
・Yasuhara J，et al. COVID-19 and multisystem inflammatory syndrome in children: A systematic review and metaanalysis. Pediatric Pulmonology 2020.
・Zambrano LD，et al. Update: Characteristics of symptomatic women of reproductive age with laboratory-confirmed
SARS-CoV-2 infection by pregnancy status — United States，January 22–October 3，2020. MMWR 2020．
・Zhang Q，et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 2020.
◀︎ CONTENTS
25
・Hoenigl M，et al. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet
Microb 2022.
・Horiuchi H，et al. COVID-19-related thrombosis in Japan: Final report of a questionnaire-based survey in 2020. J
Atheroscler Thromb 2021.
・Hou YJ，et al. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell 2020.
・Kanegaye JT，et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics 2009.
・Koehler P，et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM
consensus criteria for research and clinical guidance. Lancet Infect Dis 2021.
・Komine-Aizawa S，et al. Placental barrier against COVID-19. Placenta 2020.
・Lansbury L，et al. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect 2020.
・Made CI，et al. Presence of genetic variants among young men with severe COVID-19. JAMA 2020.
・Matsunaga N，et al. Clinical epidemiology of hospitalized patients with COVID-19 in Japan: Report of the COVID-19
REGISTRY JAPAN. Clin Infect Dis 2020.
・Menni C，et al. Symptom prevalence，duration，and risk of hospital admission in individuals infected with SARS-CoV-2
during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.
Lancet 2022.
・Mi SH，et al. Viral RNA load in mildly symptomatic and asymptomatic children with COVID-19，Seoul. Emerg Infect Dis
2020.
・Miller E，et al. Transmission of SARS-CoV-2 in the household setting: a prospective cohort study in children and adults
in England. J Infect 2021.
・Miyazato Y，et al. Prolonged and late-onset symptoms of coronavirus disease 2019. Open Forum Infect Dis 2020.
・Nalbandian A，et al. Post-acute COVID-19 syndrome. Nat Med 2021.
・Nishimoto Y，et al. The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan:
from the CLOT-COVID study. J Cardiol 2022.
・Oxley TJ，et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 2020.
・Patel A，et al. Multicenter epidemiologic study of coronavirus disease–associated mucormycosis，India. Emerg Infect Dis
2021．
・Peckham H，et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission.
Nat Commun 2020.
・Prattes J，et al. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a
multinational observational study by the European Confederation of Medical Mycology. Clin Microbiol Infect 2021.
・Riphagen S，et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020.
・Sakurai A，et al. Natural history of asymptomatic SARS-CoV-2 infection. N Engl J Med 2020.
・Salim SH，et al. In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study. BMJ 2020.
・Saurabh R，et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19
Infection. JAMA 2020.
・Shoji K，et al. Comparison of the clinical characteristics and outcomes of COVID-19 in children before and after the
emergence of Delta variant of concern in Japan. J Infect Chemother 2022.
・Sigal A，et al. Estimating disease severity of Omicron and Delta SARS-CoV-2 infections. Nat Rev Immunol 2022.
・Sudre CH，et al. Attributes and predictors of long COVID-19. Nat Med 2021.
・Summary of a report of 72，314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020.
・Takasago S，et al. Case report: Changes in cytokine kinetics during the course of disease in a Japanese patient with
multisystem inflammatory syndrome in children. Front Pediatr 2021.
・Takashita E，et al. Efficacy of antibodies and antiviral drugs against Covid-19 omicron variant. N Engl J Med 2022.
・Takazono T，et al. COVID-19 associated pulmonary aspergillosis: a nationwide survey by the Japanese Respiratory
Society. ERJ Open Res 2021.
・Uchida M，et al: Multisystem inflammatory syndrome in children ― A new syndrome complicated with acute heart
failure
following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Infection ―. Circ J 2021.
・UK Office for National Statistics. Comparing the risk of death involving coronavirus (COVID-19) by variant，England:
December 2021. 22 Feb 2022.
・Verdoni L，et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an
observational cohort study. Lancet 2020.
・Wei SQ，et al. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ
2021.
・WHO. COVID-19 Clinical management Living guidance. 23 Nov 2021.
・Wichmann D，et al. Autopsy findings and venous thromboembolism in patients with Covid-19. Ann Intern Med 2020.
・Wu Z，et al. Characteristics of and important lessons from the coronavirus disease 2019（COVID-19）outbreak in China :
Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020.
・Xie Y，et al. Long-term cardiovascular outcomes of COVID-19. Nat Med 2022.
・Yasuhara J，et al. COVID-19 and multisystem inflammatory syndrome in children: A systematic review and metaanalysis. Pediatric Pulmonology 2020.
・Zambrano LD，et al. Update: Characteristics of symptomatic women of reproductive age with laboratory-confirmed
SARS-CoV-2 infection by pregnancy status — United States，January 22–October 3，2020. MMWR 2020．
・Zhang Q，et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 2020.
◀︎ CONTENTS
25